Abatacept for rheumatoid arthritis-Reference-Cited by-同舟云学术

Abatacept for rheumatoid arthritis

Published:2009-10-07 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Maxwell Lara¹,Singh Jasvinder A²

Affiliation:

1. University of Ottawa; Institute of Population Health; 1 Stewart Street Ottawa Ontario Canada K1N 6N5

2. Minneapolis VA Medical Center; Medicine; 1 Veterans Drive Rheumatology (111R) Minneapolis MN USA 55417

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD007277.pub2/fullpdf

Reference65 articles.

1. Treatment impact on estimated medical expenditure and job loss likelihood in rheumatoid arthritis: re-examining quality of life outcomes from a randomized placebo-controlled clinical trial with abatacept;Cole;Rheumatology,2008

2. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition;Genovese;New England Journal of Medicine,2005

3. Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial;Westhovens;Rheumatology,2006

4. Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life;Emery;Journal of Rheumatology,2006

5. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial;Kremer;Arthritis & Rheumatism,2005

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Up-and-Coming Drugs for the Treatment of Vitiligo;ANN DERMATOL;2024

2. Transverse Myelitis: An Adverse Reaction to Abatacept;Cureus;2024-04-28

3. Therapeutic advances in rheumatoid arthritis;BMJ;2024-01-17

4. Immune checkpoints in rheumatoid arthritis: progress and promise;Frontiers in Immunology;2023-11-24

5. The Immunobiological Agents for Treatment of Antiglomerular Basement Membrane Disease;Medicina;2023-11-16